OraSure Technologies, Inc. announced that The Center for Biologics Evaluation and Research (CBER) of the Food and Drug Administration (FDA) has approved a labeling change to the OraQuick® HIV Self-Test that will increase access to HIV testing for adolescents. The change expands the approved age range to include individuals 14 years of age and older for the OraQuick® HIV Self-Test. Previously the test was approved for use in those 17 and older.
Read the full company press release here.
Source : OraSure Technologies, Inc.
Related HIV and Co-Infections News
-
Johns Hopkins Medicine: US: HIV infections would increase by 10% average if CDC funding for HIV testing ends
-
CHAI: Market Memo: Integrated screening for triple elimination of HIV, syphilis, and hepatitis B
-
[CROI 2026] aidsmap: Younger, mobile men especially likely to not know they have HIV in eastern and southern Africa
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.